Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 23

Trial Status

Recruiting2
Terminated1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT06909110Phase 1/2Recruiting
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
PrincipalinvestigatorStart date: 2025-04-30
NCT05241444Phase 1Recruiting
CD4^LVFOXP3 in Participants With IPEX
IPEX
PrincipalinvestigatorStart date: 2022-03-22
NCT04364178Phase 1/2Terminated
Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus
PrincipalinvestigatorStart date: 2020-08-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06909110Phase 1/2PrincipalInvestigator

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Recruiting
NCT05241444Phase 1PrincipalInvestigator

CD4^LVFOXP3 in Participants With IPEX

IPEX
Recruiting
NCT04364178Phase 1/2PrincipalInvestigator

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus
Terminated
NCT06986382Phase 1/2PrincipalInvestigator

Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease

Crohn Disease
Not Yet Recruiting

All 4 trials loaded